Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:00 AM
Ignite Modification Date:
2025-12-25 @ 12:00 AM
NCT ID:
NCT04566458
Eligibility Criteria:
Inclusion Criteria:
Male or female patients (≥18 years of age)
Patients with stage IV breast cancer
Patients with HER2+ status in metastatic setting
Patients that received at least two lines of active anti-cancer drugs due to disease progression.
Patients that began third-line therapy prior to October 31, 2018.
Exclusion Criteria:
Patients treated with an investigational anticancer agent in the ≥ 3rd line setting
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04566458
Study Brief:
Protocol Section:
NCT04566458